Granules India Limited DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Granules India posts Q4 FY25 PAT at Rs. 152 Cr

29 May 2025

// PRESS RELEASE

Granules India completes acquisition of Senn Chemicals

14 Apr 2025

// PRESS RELEASE

Granules India, AIG Hospitals host breast health camp for Telanga

04 Apr 2025

// EXPRESSPHARMA

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

CPhI WW Frankfurt

Booth #H9.1A48

Book a meeting

envelop Contact Supplier

DIGITAL CONTENT

1 Vlog #PharmaReel, 7 Corporate Content #SupplierSpotlight, 1 Data Compilation #PharmaFlow, 192 News #PharmaBuzz

media
1 Vlog #PharmaReel
7 Corporate Content #SupplierSpotlight
1 Data Compilation #PharmaFlow
192 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

75 All APIs, 43 USDMF, 18 CEP/COS, 2 JDMF, 21 EU WC, 32 KDMF, 56 NDC API, 35 Listed APIs

75 All APIs
43 USDMF
18 CEP/COS
2 JDMF
21 EU WC
32 KDMF
56 NDC API
35 Listed APIs

DEVELOPMENTS

39 Drugs in Development

39 Drugs in Development

FINISHED DOSAGE FORMULATIONS

404 FDF Dossiers, 166 FDA Orange Book, 3 Canada, 235 Listed Dossiers

404 FDF Dossiers
166 FDA Orange Book
3 Canada
235 Listed Dossiers

KEY PRODUCTS

Avatrombopag Maleate, Bupropion Hydrochloride, Cabozantinib, Elacestrant, Eltrombopag, Empagliflozin, Esomeprazole Magnesium, Gabapentin, Guaifenesin, Levocetirizine Dihydrochloride, Metformin, Methocarbamol, Metoprolol Succinate, Paracetamol, Trazodone Hydrochloride

Avatrombopag Maleate
Bupropion Hydrochloride
Cabozantinib
Elacestrant
Eltrombopag
Empagliflozin
Esomeprazole Magnesium
Gabapentin
Guaifenesin
Levocetirizine Dihydrochloride
Metformin
Methocarbamol
Metoprolol Succinate
Paracetamol
Trazodone Hydrochloride

INSPECTIONS & REGISTRATIONS

23 FDA, 15 EDQM, 6 GDUFA

inspections
23 FDA
15 EDQM
6 GDUFA

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

About

Granules is a fast-growing, vertically integrated pharma company based in Hyderabad, committed to operational excellence, quality, and customer service. It manufactures across the entire value chain- APIs, Formulation Intermediates, & Formulations. With 11 facilities (8 in India, 2 in the US and 1 in Europe) approved by US FDA, EDQM, EU GMP, WHO GMP, & more, its products reach 300+ customers in 80+ countries. Granules has offices in India, the US, & Europe ensuring a strong global presence.

Products listed herein may not be available for commercial use in countries where any relevant third-party intellectual property is in force.

CPhI South East AsiaCPhI South East Asia

Industry Trade Show

Not Confirmed

16-18 July, 2025

MITEC, Kuala Lumpur, Malaysia
CPhI WW FrankfurtCPhI WW Frankfurt

Industry Trade Show

Booth #H9.1A48

28-30 October, 2025

Frankfurt
CPhI IndiaCPhI India

Industry Trade Show

Attending

25-27 November, 2025

India Expo Centre, Greater Noida

CONTACT DETAILS

Click the arrow to open the dropdown

Country

India

Address

15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad – 500...

Telephone

+91 4069043500

sales@granulesindia.com

Website

https://granulesindia.com/

https://www.linkedin.com/company/granules-india-limited/

YouTube

Digital content

Explore the latest content creation from this company

VLOG #PharmaReel

Integrated player offering APIs, PFIs & Formulations

Granules India stands as a truly integrated pharmaceutical powerhouse, delivering APIs, PFIs, and formulations with a focus on scale and sustainability. Its growing portfolio now spans CNS/ADHD, Diabetes, and Oncology.

Impressions: 458

CORPORATE CONTENT #SupplierSpotlight

Product List 2025

Open PDF

Upload

Corporate Presentation

Open PDF

Upload

API Product List 2025

Open PDF

Upload

FDF Product List 2025

Open PDF

Upload

PFI Product List 2025

GMP Certificate 2025

DATA COMPILATION #PharmaFlow

DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutical industry. These files, submitted to the US Food and Drug Administration (FDA), contain detailed information about ingredients, manufacturing processes, and packaging of medicines. They help the FDA oversee drug quality. Of the four types, Type II DMFs involve active pharmaceutical ingredients (APIs) for both branded and generic drugs. The third quarter (Q3) of 2024 saw Type II DMF submissions set a new record. A total of 309 Type II DMFs were submitted to the FDA during this period, a substantial 24.6 percent increase over Q3 2023 (with 248 submissions). The second quarter of 2024 too saw a remarkable increase, with 237 Type II DMFs being submitted compared to 178 in Q2 2023. View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) China witnesses steep rise in DMF submissions, beats India with maximum filings In Q3 2024, China filed 153 DMFs submissions, marking a substantial 57.7 percent increase from the 97 submissions filed in Q3 2023. India maintained its strong position but fell to the number two spot with 110 DMFs, representing a modest 3.8 percent increase from 106 in Q3 2023. The US, which came a distant third, saw a slight decline in DMF submissions, with 13 filed in Q3 2024, as compared to 18 in Q3 2023. For several years, India had a lead in Type II DMFs. Since 2020, which marked the start of the pandemic, we have noticed a gradual increase in DMFs filed by China. This year, China has surpassed India considerably in the first three quarters. During the first nine months of 2024, China submitted 372, while India filed 286 DMFs. If this lead is maintained in Q4, DMFs from China will surpass that of India in 2024. Amongst European countries, Spain led with seven DMFs, followed by Italy at four, and Germany and the Netherlands at three each. Among other nations, Japan contributed six while Israel submitted four DMFs. In company-wise tally, China’s Jiangsu East-Mab Biomedical Technology topped the list with an impressive 14 DMFs. On its heels were Indian companies — MSN at 13 DMFs, and Vamsi Labs and Hetero Drugs at nine DMFs each. China’s Porton Pharma and Wuxi AppTec filed five, while Shanghai Keze Yongxin Biotechnology, and Qingdao Glycogene Pharmaceutical contributed four submissions each. India's Maithri Drugs also submitted four. Japanese company Santeja filed five. Overall, Asia accounted for nearly 90 percent, with China contributing a dominant 49.5 percent of all DMF submissions. India was at 35.6 percent, the US at 4.2 percent, while Europe contributed 6.5 percent. View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) Diabetes, obesity, cancer, women’s health drugs emerge as hot molecules in Q3 2024 In terms of molecules, semaglutide (used for the treatment of type 2 diabetes and weight management) and relugolix (to treat prostate cancer and uterine fibroids) saw six DMF filings each in Q3 2024, indicating significant industry interest in these compounds. Following closely behind were semaglutide’s competitor tirzepatide and overactive bladder therapy vibegron, garnering four DMFs each. Finerenone (a non-steroidal drug for chronic kidney disease associated with type 2 diabetes) and voclosporin (an immunosuppressant for lupus nephritis) saw three DMFs each. The last quarter also witnessed the introduction of 14 molecules with first-time DMFs. Among them were acetoxy empagliflozin, cabozantinib fumarate, tivozanib hydrochloride monohydrate, diosmetin, trilaciclib, clenbuterol hydrochloride, fenoterol hydrobromide, tapinarof and fezolinetant. Fezolinetant, with a DMF from Spain’s Moehs Iberica, is the active ingredient in Astellas’ Veozah, which is the first non-hormonal treatment for menopausal symptoms approved by the FDA. Tapinarof, filed by India’s Maithri Drugs, is used in Vtama, a novel steroid-free psoriasis cream. Other compounds that made their DMF debut include berotralstat, calcium phosphoryl choline chloride, phloroglucinol dihydrate, belumosudil mesylate and trimethylphloroglucinol. During Q2 2024, there were 19 drugs that saw DMF submissions for the first time, including molecules like triptorelin, sorafenib, pralsetinib, trilaciclib dihydrochloride, resmetirom (hepatology) and teneligliptin hydrochloride hydrate (metabolic disorders). View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) GDUFA fee for FY 2025: The FDA’s Generic Drug User Fee Amendments (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public and reduce costs to the industry. The fiscal year 2025 fee rates were published on July 31, 2024. The FDA has revised fees under GDUFA III for all categories. While there is a slight increase in the DMF fee from US$ 94,682 in 2024 to US$ 95,084 in 2025, the ANDA fee has witnessed a significant jump — from US$ 252,453 in 2024 to US$ 321,920 in 2025. FY 2024 and FY 2025 User Fee Rates Generic drug fee category Fees rates for FY 2024 Fees rates for FY 2025 Applications: Abbreviated New Drug Application (ANDA) US$ 2,52,453 US$ 3,21,920 Drug Master File (DMF) US$ 94,682 US$ 95,084 Facilities: Active Pharmaceutical Ingredient (API)—Domestic US$ 40,464 US$ 41,580 API—Foreign US$ 55,464 US$ 56,580 Finished Dosage Form (FDF)—Domestic US$ 2,20,427 US$ 2,31,952 FDF—Foreign US$ 2,35,427 US$ 2,46,952 Contract Manufacturing Organization (CMO)—Domestic US$ 52,902 US$ 55,668 CMO—Foreign US$ 67,902 US$ 70,668 GDUFA Program: Large size operation generic drug applicant US$ 17,29,629 US$ 18,91,664 Medium size operation generic drug applicant US$ 6,91,852 US$ 7,56,666 Small business generic drug applicant US$ 1,72,963 US$ 1,89,166 Our view The highlight of the last few quarters has been the sharp rise in Type II DMF filings from China. The submission of a DMF is not required by law or any FDA regulation. FDA’s DMF guideline offers guidance on acceptable approaches to meeting regulatory requirements. Moreover, DMFs establish trust in APIs from lesser-known companies. With a growing emphasis on compliance and quality assurance, it appears that Chinese drug companies are eager to demonstrate their commitment to high standards and build trust in the US market. And that’s good news for the pharmaceutical industry.

Impressions: 7767

NEWS #PharmaBuzz

Granules India posts Q4 FY25 PAT at Rs. 152 Cr

29 May 2025

// PRESS RELEASE

Granules India completes acquisition of Senn Chemicals

14 Apr 2025

// PRESS RELEASE

Granules India, AIG Hospitals host breast health camp for Telanga

04 Apr 2025

// EXPRESSPHARMA

Granules India acquires Senn Chemical to foray into peptide & CDMO

22 Feb 2025

// PRESS RELEASE

Granules Strengthens ADHD Portfolio with FDA Approval

30 Jan 2025

// PRESS RELEASE

Granules India Q3 FY25 PAT drops 6% to Rs 118 Cr

27 Jan 2025

// PRESS RELEASE

ALL APIs

Click the button for full data set

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

01

Acetaminophen Usp

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

GDUFA

DMF Review : Complete

Rev. Date : 2013-06-08

Pay. Date : 2012-11-29

DMF Number : 19804

Submission : 2006-09-28

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Market
Place

02

Atazanavir Sulfate

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 32259

Submission : 2017-12-27

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Market
Place

03

Bupropion Hydrochloride Usp

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

GDUFA

DMF Review : Complete

Rev. Date : 2021-05-27

Pay. Date : 2021-04-15

DMF Number : 35694

Submission : 2021-03-29

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Market
Place

04

Cetirizine Hydrochloride, Usp

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

GDUFA

DMF Review : Complete

Rev. Date : 2016-03-23

Pay. Date : 2015-12-14

DMF Number : 30063

Submission : 2016-02-01

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Market
Place

05

Compresso Ggf 95 Sa (guaifenesin Gra...

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 20998

Submission : 2007-10-31

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Market
Place

06

Compresso Ibu 66s

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 20606

Submission : 2007-06-12

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Market
Place

07

Compresso Ibu 85 Par (ibuprofen Gran...

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 35886

Submission : 2021-05-18

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Market
Place

08

Compresso Lsp 33.333 % (losartan Pot...

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 36088

Submission : 2021-07-12

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Market
Place

09

Compresso Mf 95p

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 17723

Submission : 2004-09-22

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Market
Place

10

Compresso Pap 90 Cpc

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 19972

Submission : 2006-11-16

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Market
Place

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

01

Acetaminophen

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Registrant Name : Daeshin Pharmaceutical Co., Ltd.

Registration Date : 2005-09-15

Registration Number : 20050915-32-C-198-10

Manufacturer Name : Granules India Ltd

Manufacturer Address : H. No.: 6-5 & 6-11, Temple Road, Bonthapally Village, Gummadidala Mandal, Sangareddy ...

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

02

Acetaminophen

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Registrant Name : Insung Trading Co., Ltd.

Registration Date : 2023-03-29

Registration Number : 20050915-32-C-198-10(B)

Manufacturer Name : Granules India Ltd

Manufacturer Address : H.No.6-5 & 6-11, Temple Road, Bonthapally Village, Gummadidala Mandal, Sangareddy Dis...

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

03

Acetaminophen

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Registrant Name : Johnson & Johnson Korea Sales Co., Ltd.

Registration Date : 2023-03-03

Registration Number : 20050915-32-C-198-10(A)

Manufacturer Name : Granules India Ltd

Manufacturer Address : H.No.6-5 & 6-11, Temple Road, Bonthapally Village, Gummadidala Mandal, Sangareddy Dis...

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

04

Fexofenadine hydrochloride

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Registrant Name : Pharmapia Co., Ltd.

Registration Date : 2025-03-11

Registration Number : 20250311-209-J-1810

Manufacturer Name : M/s. Granules India Limited (U...

Manufacturer Address : Plot No.08, Jawaharlal Nehru Pharma City, Parawada Mandal, Visakhapatnam Dist 531 019...

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

05

Guaifenesin

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Registrant Name : Daeshin Pharmaceutical Co., Ltd.

Registration Date : 2021-07-05

Registration Number : 20210309-211-J-857(2)

Manufacturer Name : Granules India Limited

Manufacturer Address : 15A/1, IDA, Phase-III, Jeedimetla, Quthbullapur Mandal, Malkajgiri Dist – 500055, T...

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

06

Guaifenesin

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Registrant Name : IMCD Korea Co., Ltd.

Registration Date : 2021-06-04

Registration Number : 20210309-211-J-857(1)

Manufacturer Name : Granules India Limited

Manufacturer Address : 15A/1, IDA, Phase-III, Jeedimetla, Quthbullapur Mandal, Malkajgiri Dist-500 055.,Tela...

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

07

Guaifenesin

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Registrant Name : Hwail Pharmaceutical Co., Ltd.

Registration Date : 2021-11-30

Registration Number : 20210309-211-J-857(3)

Manufacturer Name : Granules India Limited

Manufacturer Address : 15A/1, IDA, Phase-III, Jeedimetla, Quthbullapur Mandal, Malkajgiri Dist – 500055, T...

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

08

Guaifenesin

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Registrant Name : Insung Trading Co., Ltd.

Registration Date : 2021-03-09

Registration Number : 20210309-211-J-857

Manufacturer Name : Granules India Limited

Manufacturer Address : 15A/1, IDA, Phase-III, Jeedimetla, Quthbullapur Mandal, Malkajgiri Dist – 500055, T...

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

09

Levocetirizine hydrochloride

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Registrant Name : Hiple Co., Ltd.

Registration Date : 2016-05-02

Registration Number : 20090720-40-C-258-15(3)

Manufacturer Name : Granules India Limited

Manufacturer Address : Plot No 8, Jawaharlal Nehru Pharma City, Tadi Village, Parawada Mandal, Vitsakhapatna...

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

10

Levocetirizine hydrochloride

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Registrant Name : Dongkwang Pharmaceutical Co., Ltd.

Registration Date : 2016-02-25

Registration Number : 20090720-40-C-258-15(2)

Manufacturer Name : Granules India Limited

Manufacturer Address : Plot No 8, Jawaharlal Nehru Pharma City, Tadi Village, Parawada Mandal, Vitsakhapatna...

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

Only 10 entries up to this point, click to access all

LISTED APIs

01

Atazanavir Sulfate

India

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Granules India Limited

Products listed herein may not be available for commercial use in countries where any relevant third-party intellectual property is in force.

Product
Web Link

Stock Recap
#Pipeline Prospector

Market
Place

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KEY PRODUCTS

TOP RANKED SUPPLIER FOR:

Inspections and registrations

Check the inspections & registration from this company

FDA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EDQM

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

GDUFA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact Granules India Limited and get a quotation

Granules India Limited is a supplier offers 50 products (APIs, Excipients or Intermediates).

Find a price of Metformin bulk with DMF, CEP, JDMF offered by Granules India Limited

Find a price of Paracetamol bulk with DMF, CEP, JDMF offered by Granules India Limited

Find a price of Atazanavir Sulfate bulk with DMF, CEP offered by Granules India Limited

Find a price of Guaifenesin bulk with DMF, CEP offered by Granules India Limited

Find a price of Losartan Potassium bulk with DMF, CEP offered by Granules India Limited

Find a price of Metformin bulk with DMF, CEP offered by Granules India Limited

Find a price of Pirfenidone bulk with DMF, CEP offered by Granules India Limited

Find a price of Rifaximin bulk with DMF, CEP offered by Granules India Limited

Find a price of Trazodone Hydrochloride bulk with DMF, CEP offered by Granules India Limited

Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP offered by Granules India Limited

Find a price of Esomeprazole Magnesium bulk with DMF, CEP offered by Granules India Limited

Find a price of Levetiracetam bulk with DMF, CEP offered by Granules India Limited

Find a price of Omeprazole bulk with DMF, CEP offered by Granules India Limited

Find a price of Pantoprazole Sodium bulk with DMF, CEP offered by Granules India Limited

Find a price of Sorafenib bulk with DMF, CEP offered by Granules India Limited

Find a price of Dimethyl Fumarate bulk with DMF offered by Granules India Limited

Find a price of Eltrombopag bulk with DMF offered by Granules India Limited

Find a price of Fexofenadine Hydrochloride bulk with DMF offered by Granules India Limited

Find a price of Levocetirizine Dihydrochloride bulk with DMF offered by Granules India Limited

Find a price of Metformin bulk with CEP offered by Granules India Limited

Find a price of Methocarbamol bulk with DMF offered by Granules India Limited

Find a price of Metoprolol Succinate bulk with DMF offered by Granules India Limited

Find a price of Omeprazole Magnesium bulk with DMF offered by Granules India Limited

Find a price of Paracetamol bulk with DMF offered by Granules India Limited

Find a price of Bupropion Hydrochloride bulk with DMF offered by Granules India Limited

Find a price of Dapagliflozin bulk with DMF offered by Granules India Limited

Find a price of Dasatinib bulk with DMF offered by Granules India Limited

Find a price of Empagliflozin bulk with DMF offered by Granules India Limited

Find a price of Esomeprazole Magnesium bulk with DMF offered by Granules India Limited

Find a price of Ibuprofen bulk with DMF offered by Granules India Limited

Find a price of Linagliptin bulk with DMF offered by Granules India Limited

Find a price of Losartan Potassium bulk with DMF offered by Granules India Limited

Find a price of Nilotinib bulk with DMF offered by Granules India Limited

Find a price of Pazopanib Hydrochloride bulk with DMF offered by Granules India Limited

Find a price of Prazosin Hydrochloride bulk with DMF offered by Granules India Limited

Find a price of Ruxolitinib Phosphate bulk with DMF offered by Granules India Limited

Find a price of Vigabatrin bulk with DMF offered by Granules India Limited

Find a price of Gabapentin bulk offered by Granules India Limited

Find a price of Tenofovir Disoproxil Succinate bulk offered by Granules India Limited

Find a price of Avatrombopag Maleate bulk offered by Granules India Limited

Find a price of Cabozantinib bulk offered by Granules India Limited

Find a price of Elacestrant bulk offered by Granules India Limited

Find a price of Eltrombopag bulk offered by Granules India Limited

Find a price of Guaifenesin bulk offered by Granules India Limited

Find a price of Ibuprofen bulk offered by Granules India Limited

Find a price of Lapatinib Ditosylate bulk offered by Granules India Limited

Find a price of Levocetirizine Dihydrochloride bulk offered by Granules India Limited

Find a price of Metformin bulk offered by Granules India Limited

Find a price of Methocarbamol bulk offered by Granules India Limited

Find a price of Paracetamol bulk offered by Granules India Limited

Company profile for Granules India Limited

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

DIGITAL CONTENT

1 Vlog #PharmaReel

7 Corporate Content #SupplierSpotlight

1 Data Compilation #PharmaFlow

192 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

75 All APIs

43 USDMF

18 CEP/COS

2 JDMF

21 EU WC

32 KDMF

56 NDC API

35 Listed APIs

DEVELOPMENTS

39 Drugs in Development

FINISHED DOSAGE FORMULATIONS

404 FDF Dossiers

166 FDA Orange Book

3 Canada

235 Listed Dossiers

KEY PRODUCTS

INSPECTIONS & REGISTRATIONS

23 FDA

15 EDQM

6 GDUFA

01

02

03

04

05

06

07

08

09

10

Daeshin Pharmaceutical Co., Ltd.

2005-09-15

20050915-32-C-198-10

Granules India Ltd

India

H. No.: 6-5 & 6-11, Templ...

01

Insung Trading Co., Ltd.

2023-03-29

20050915-32-C-198-10(B)

Granules India Ltd

India

H.No.6-5 & 6-11, Temple R...

02

Johnson & Johnson Korea Sales Co., Ltd.

2023-03-03

20050915-32-C-198-10(A)

Granules India Ltd

India

H.No.6-5 & 6-11, Temple R...

03

Pharmapia Co., Ltd.

2025-03-11

20250311-209-J-1810

M/s. Granules India Limit...

India

Plot No.08, Jawaharlal Ne...

04

Daeshin Pharmaceutical Co., Ltd.

2021-07-05

20210309-211-J-857(2)

Granules India Limited

India

15A/1, IDA, Phase-III, Je...

05

IMCD Korea Co., Ltd.

2021-06-04